% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eyesandears51 eyesandears51 Oct 3, 2012 1:48 PM Flag

    News from European Society of Medical Oncology


    We may be in violent agreement, adjusting for different time perspectives. Long term very bullish, with short term pronounced swings up and down. The uncertain and highly volatile macro environment over the past several years, and the resultant potential need to raise or re-deploy assets quickly, is always on the near term horizon. For those investors, including myself, the ability to liquidate MACK or other holdings, if necessary, quickly and without financial damage, is dependent on selecting an entry or add to price where the likelihood of a significant decline is minimized. Today's price drop supports the view that an entry price of $ 8.06- $ 8.56 is more compatible with my risk/reward and time frame objectives. Your greater tolerance for 20% up/down swings is fully consistent with a much longer time perspective.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Exactly. I'm too busy with the rest of my life to trade in and out, and frankly when I look back on the days when I did do that I didn't make out any better than I am now. Glad to hear we are on the same side, and good luck with your methodology. Bottom line this is a very neat company to know about and share in the growth of, and the next few years look exceptionally promising.

5.83+0.22(+3.92%)12:08 PMEDT